Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-014938
Filing Date
2021-03-24
Accepted
2021-03-23 21:15:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A life-defa14a_20210428.htm DEFA14A 31262
2 GRAPHIC g3ti4syvy214000001.jpg GRAPHIC 5930
3 GRAPHIC g3ti4syvy214000002.jpg GRAPHIC 18991
  Complete submission text file 0001564590-21-014938.txt   66884
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37378 | Film No.: 21766353
SIC: 2836 Biological Products, (No Diagnostic Substances)